
TetraScience offers a Scientific Data and AI Cloud designed to liberate, unify, and transform raw scientific data into AI-native data. This platform aims to enable Scientific AI by providing a purpose-built, open, and collaborative environment. Key products include the Scientific Data and AI Cloud, Chromatography Insights App, GxP Compliance, and Tetra Sciborgs. The company emphasizes its vendor-agnostic approach, preventing proprietary data silos and vendor lock-in. TetraScience claims to increase scientist productivity by 10x, speed up production insights by 40x, and reduce time to market by 60%. They have a significant customer base with 48% of top pharma companies using their services and 46% of employees having a life sciences background. The company focuses on enabling AI for discovery and optimizing research productivity, aiming to reduce wet lab work and redirect scientists' time to higher-value activities.

TetraScience offers a Scientific Data and AI Cloud designed to liberate, unify, and transform raw scientific data into AI-native data. This platform aims to enable Scientific AI by providing a purpose-built, open, and collaborative environment. Key products include the Scientific Data and AI Cloud, Chromatography Insights App, GxP Compliance, and Tetra Sciborgs. The company emphasizes its vendor-agnostic approach, preventing proprietary data silos and vendor lock-in. TetraScience claims to increase scientist productivity by 10x, speed up production insights by 40x, and reduce time to market by 60%. They have a significant customer base with 48% of top pharma companies using their services and 46% of employees having a life sciences background. The company focuses on enabling AI for discovery and optimizing research productivity, aiming to reduce wet lab work and redirect scientists' time to higher-value activities.
What they do: Provide a vendor-agnostic Scientific Data and AI Cloud to harmonize and operationalize laboratory and R&D data for life sciences.
Founded: 2014
HQ: Boston, MA
Notable funding: Series B $80M co-led by Insight Partners and Alkeon Capital (Apr 2021)
Laboratory and R&D data integration, harmonization, and preparation for AI-driven analysis in life sciences.
2014
Software Development
Early seed round with investors including Rough Draft Ventures, Founder Collective, Floodgate, First Round Capital.
8,000,000
Series A included Waters Corporation joining Floodgate Capital, First Round Capital, Underscore VC, Founder Collective, and Y Combinator.
80,000,000
Series B announced April 15, 2021.
“Has attracted strategic and growth investors including Waters Corporation, Insight Partners, and Alkeon Capital across rounds.”
| Company |
|---|